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Reprogramming cellular metabolism helps support T cell growth and effector function upon activation. In this
issue of Immunity, Nakaya et al. (2014) report that the glutamine transporter ASCT2 regulates T cell meta-
bolism and mTOR kinase signaling to shape inflammatory T helper cell responses.T lymphocytes are central effectors of
the adaptive immune system, and their
proper function is critical to mediate
long-lasting immunity to foreign patho-
gens. Upon activation by antigens, naive
CD4+ T cells expand and differentiate
into specific T helper (Th) cell populations,
including Th1, Th2, and Th17 cells, each
with specific effector functions tailored
toward the given pathogen. Although
proinflammatory Th responses are impor-
tant for mediating immunity to foreign
pathogens, unchecked or misdirected
Th cell responses can also promote
inflammation and autoimmunity. One of
the fundamental programs that helpsdrive
T cell activation is the regulation of cellular
metabolism, the series of biochemical
reactions that mediate cellular energy
production and biosynthesis. The pre-
dominant metabolic program of activated
CD4+ Th cells is a shift to aerobic glycol-
ysis (also known as the ‘‘Warburg Effect’’),
a progrowth metabolic program that
generates both ATP and macromolecules
required for T cell proliferation (MacIver
et al., 2013). Amino acids (AAs) are also
key nutrients for T cells, because they
can serve as both a fuel source and
a pool of biosynthetic precursors for
protein and nucleic acid biosynthesis. Of
particular relevance to T cell biology is
the nonessential amino acid (NEAA) gluta-mine, which is rapidly taken up by T cells
upon activation (Carr et al., 2010; Wang
et al., 2011). However, the importance
of glutamine to CD4+ T cell-mediated
immune responses in vivo has been diffi-
cult to study. Here, Nakaya et al. (2014)
demonstrate that the alanine, serine,
and cysteine (ASC) system AA trans-
porter 2 (ASCT2) is a key regulator
of glutamine uptake in CD4+ Th cells and
influences the development of proinflam-
matory Th1 and Th17 responses in vitro
and in vivo.
ASCT2 is a sodium-dependent, neutral
amino acid transporter encoded by
SLC1A5 that mediates the cotransport of
Na+ along with glutamine (or other neutral
AAs such as alanine, cysteine, serine,
and threonine) with high affinity (Figure 1).
However, in addition to ASCT2, there are
a number of AA transporters expressed
by activated T cells, including the so-
dium-coupled neutral AA transporters
SNAT1 and SNAT2 (Carr et al., 2010; Sin-
clair et al., 2013), which are capable of
transporting glutamine. By using gene-
targeted mice lacking ASCT2 expression
(Asct2/ mice), Nakaya et al. (2014)
demonstrated that glutamine uptake
by T cells, both short-term (30 min) and
long-term (>20 hr) postactivation, were
markedly reduced in CD4+ T cells from
Asct2/ mice. These data indicate thatASCT2 is a major regulator of glutamine
transport in T lymphocytes. Activated
Asct2/ T cells also displayed reduced
rates of glucose uptake, lactate produc-
tion (an indicator of aerobic glycolysis),
and oxygen consumption (a mea-
surement of oxidative phosphorylation
[OXPHOS]), suggesting that themetabolic
program normally triggered by TCR stim-
ulation was attenuated in T cells lacking
ASCT2. The authors attributed these ob-
servations to reduced expression of the
glucose transporter Glut1 and transcrip-
tion factor c-Myc, both key components
of metabolic reprogramming in T cells
(MacIver et al., 2013), in Asct2/ T cells.
Addition of exogenous glutamine restored
the glycolytic defect of ASCT2-deficient
T cells, suggesting that glutamine avail-
ability can directly impact other metabolic
programs required for T cell proliferation.
Mechanistically, the authors identified
the CARMA1-BCL10-MALT1 (CBM) sig-
nalosome, a signaling complex that acti-
vates nuclear factor-kB (NF-kB) signaling
downstream of the TCR (Thome, 2004), as
a regulator of TCR-mediated glutamine
uptake and ASCT2 expression in T cells
(Figure 1). Regulation of glutamine uptake
by the CBM complex appeared to be
independent from CBM-dependent NF-
kB activation, as IKKb-deficient T cells
displayed no impairment in glutamine40, May 15, 2014 ª2014 Elsevier Inc. 635
Figure 1. Regulation of CD4+ T Helper Cell Function by ASCT2-Mediated Amino Acid
Transport
TCR-dependent glutamine (Gln) import by the Na+-dependent neutral amino acid transporter ASCT2
(orange) promotes the development of proinflammatory CD4+ Th1 and Th17 cell responses. ASCT2
cotransports extracellular Na+ and Gln, with the latter used to import leucine (Leu) via the Slc7a5-
Slc3a2 antiporter (green). The Slc7a5-Slc3a2 complex is also known as CD98. Leu promotes the activa-
tion of mTORC1 (purple), which regulates both T cell metabolism and Th1 and Th17 cell differentiation.
Glutamine might also exert effects on mTORC1 activation through indirect mechanisms. ASCT2 expres-
sion is regulated downstream of TCR and CD28 signaling by the CARMA1-BCL10-MALT1 (CBM) complex
(yellow). In the absence of ASCT2, Gln and Leu uptake by CD4+ T cells is reduced, leading to decreased
mTORC1 activity and attenuated CD4+ Th1 and Th17 responses. T cell proliferation and IL-2 production
are unaffected in Asct2/ T cells.
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Previewstransport. CARMA1 was shown to regu-
late both the expression of ASCT2
mRNA and colocalization of ASCT2 with
the TCR. CARMA1 immunoprecipitated
with ASCT2 in overexpression studies
in HEK293 cells, suggesting a possible
interaction between CBM-ASCT2.
To explore the role of ASCT2 in CD4+
T cell function, Nakaya et al. examined
the impact of ASCT2 loss on peripheral
lymphocyte homeostasis. While periph-
eral T and B cell numbers were compara-
ble between young (6- to 7-week-old)
Asct2+/+ and Asct2/ mice, the authors
observed a progressive decline in CD4+
T cell numbers in aged (>5 months)
Asct2/ mice, with noticeable changes
in the number and frequency of
CD4+CD44hiCD62lo T effector memory636 Immunity 40, May 15, 2014 ª2014 Elsevi(Tem) cells. The authors observed a drop
in the number of Th1 (interferon-g [IFN-
g]-producing) and Th17 (IL-17-producing)
cells in the CD4+ Tem cell population,
whereas the frequency of CD4+Foxp3+ T
regulatory (Treg) cells was unaffected by
loss of ASCT2. Loss of ASCT2 did not
alter rates of T cell proliferation or IL-2
production in response to anti-CD3 and
anti-CD28 stimulation in vitro (surprising,
given the reduction in glucose meta-
bolism and OXPHOS in Asct2/ T cells).
However, the authors observed a reduc-
tion in the ability of naive Asct2/ CD4+
T cells to differentiate into Th1 and Th17
cells, but not Th2 or Treg cells, in vitro.
The authors next askedwhether ASCT2
deficiency could affect Th1 or Th17
responses in vivo by using three well-er Inc.established experimental models: (1) Th1
and Th17 cell-mediated colitis follow-
ing adoptive transfer of naive CD4+
CD45RBhi T cells into Rag1/ mice,
(2) Th1 cell responses following infec-
tion with the Gram-negative bacterium
L. monocytogenes, and (3) Th1 and
Th17-mediated induction of experimental
autoimmune encephalomyelitis (EAE)
following immunization with myelin oligo-
dendrocyte glycoprotein (MOG) peptide.
The results from each experimental
model were clear: lack of ASCT2 resulted
in reduced numbers of IFN-g- and/or IL-
17A-producing CD4+ T cells in vivo. Re-
sults from the EAE experiments were
particularly striking, with Asct2/ mice
displaying reduced infiltration of IFN-g+
and IL-17+ T cells in the central nervous
system (CNS) and overall reduced
severity of EAE disease. These results
highlight a central role for ASCT2 in estab-
lishing proper Th1- and Th17-cell-medi-
ated immune responses.
How does an amino acid transporter
exert such a dramatic effect on T cell-
mediated immune responses? The au-
thors observed that TCR-dependent
activation of mammalian target of rapa-
mycin complex 1 (mTORC1) signaling
was defective in T cells lacking ASCT2.
mTORC1 is a serine/threonine kinase
complex that couples growth factor sig-
nals, nutrient availability, and cellular en-
ergy status to the regulation of cell growth
andmetabolism in lymphocytes and plays
a prominent role in the differentiation
of CD4+ effector T cells (Zeng and Chi,
2013). CD4+ T cells deficient for the small
GTPase Rheb, which regulates mTORC1
activity in T cells (Delgoffe et al., 2011),
display defects in Th1 and Th17 (but not
Th2) cell differentiation similar to that
observed with Asct2/ mice.
What links ASCT2-mediated glutamine
uptake to mTORC1 activation in T cells?
One possible explanation is that ASCT2
might work in concert with other AA
transporters to facilitate AA-dependent
mTORC1 activation. One such complex
is the Slc7a5-Slc3a2 antiporter, also
known as CD98, which imports branched
amino acids (such as leucine) while
exporting glutamine. In this model,
ASCT2 is required to generate a pool of
intracellular glutamine, which in turn
drives CD98-dependent leucine import
and leucine-dependent mTORC1 activa-
tion (Nicklin et al., 2009) (Figure 1).
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PreviewsAlternatively, glutamine might affect
mTORC1 activity through glutamine
metabolism in the tricarboxylic acid
(TCA) cycle (Dura´n et al., 2012).
Reduced glutamine import in ASCT2-
deficient T cells would reduce intracel-
lular leucine concentrations, resulting in
reduced mTORC1 signaling and atten-
uation of proinflammatory CD4+ T cell
responses (Figure 1). Indeed, TCR-stimu-
lated leucine uptake was dramatically
reduced in Asct2/ T cells; moreover,
defects in both mTORC1 activation and
Th17 differentiation could be rescued in
ASCT2-deficient T cells by the administra-
tion of exogenous leucine. Interestingly,
Cantrell and colleagues recently reported
similar defects in T cell metabolism,
mTORC1 activation, and Th1 and Th17
cell differentiation in mice harboring a
Tcell-specific deletion ofSLC7A5 (Sinclair
et al., 2013). Together these studies
provide insight into the influence of AAs
on shaping T cell-mediated immune re-
sponses, independent of their role in pro-
tein biosynthesis. It is important to note
that glutamine is not the sole AA trans-
ported by ASCT2, and whether deficiency
in the transport of other AAs contributes tothe phenotype of Asct2/ T cells remains
to be determined.
The work of Nakaya and colleagues
raises important questions regarding the
impact of nutrient availability on T cell
function. As T cells travel from sites of
immune priming in secondary lymphoid
organs to distant sites of infection, they
are likely to experience different meta-
bolic microenvironments that might
impact their function. TCR-dependent
control of nutrient transporters such as
ASCT2 might be one way that CD4+
T cells acquire sufficient nutrient levels
to maintain mTORC1 activity and T cell
effector function. Understanding the
mechanisms that coordinate—and regu-
late—proinflammatory CD4+ Th cell re-
sponses might uncover new mechanisms
for modulating T cell responses, with
applications ranging from new treatments
for autoimmune disease to improving the
effectiveness of cancer immunotherapy.
The work by Nakaya et al. (2014) indicates
that the management of metabolic re-
sources, including the import of specific
amino acids, is a critical determinant for
the proper development and function of
proinflammatory CD4+ T cell responses.ImmunityREFERENCES
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Macrophages in the gut originate from blood precursors and have distinct functional properties. In this issue
of Immunity, Zigmond et al. (2014) and Shouval et al. (2014) report that interleukin-10 drives macrophages to
express homeostatic tolerogenic functions, preventing colitis.Constant exposure to food and environ-
mental antigens and a tremendous variety
of commensal bacteria make the intestine
a vulnerable setting. Intestinal immune
cells are engaged in a robust balanced
immune response, aimed at controlling
pathogen invasion while preventing unin-
tended harmful tissue injuries. Key
players in the maintenance of gut defense
and homeostasis are intestinal mono-nuclear phagocytes, of which monocyte-
derived macrophages constitute the
most abundant population (Zigmond and
Jung, 2013). Failure in the macrophage-
mediated shaping of gut immune re-
sponses might result in deregulated
excessive inflammatory responses, as
those observed in inflammatory bowel
disorders. The immune networks govern-
ing this balance in the steady-state intes-tinal lamina propria have recently begun
to be unraveled, with the important
clinical endpoint to identify therapeutic
targets for gut chronic inflammatory dis-
eases. However, the local molecular me-
diators driving the education of intestinal
macrophages into immunomodulating
cells have not been fully identified.
This issue of Immunity features two
original articles (Zigmond et al., 2014;40, May 15, 2014 ª2014 Elsevier Inc. 637
